In the 1970’s, Taiwan enjoyed a prospering economy and a rapidly rising living standard. However, despite this increase in the country’s wealth, the quality of Taiwan’s medical services and the advancement of technologies still lagged significantly behind. Not only were there limited institutions that offered training to the local medical graduate students, those who went abroad for further training also found themselves unable to put to use their acquired skills and knowledge. Thus, the demand for medical services in Taiwan remained unmet.
In pursuit to provide the people of Taiwan with high quality healthcare, Formosa Plastic Group Chairman Yung-Ching Wang and President Yung-Tsai Wang established Chang Gung Memorial.Hospital (CGMH) in 1976 in memory of their father,Mr.Chang-Gung Wang. During the early periods of its establishment, CGMH had played the role as a mediating center that introduced modern medical knowledge and technologies from around the world to Taiwan, now it aspires tobecome a world class medical center. Our physicians, nursing staffs and medical allies work closely as a team to provide our patients with complete physical, psychological and social care.
Moreover, in order to meet the people’s growing demands for medical services, our hospitals were built in Keelung and Kaohsiung following those in Taipei & Linkou. Also, Chang-Gung Institute of Nursing and Chang-Gung University were established. The University and the Hospital work effectively together by complementing each other and its collaboration facilitate both basic research and clinical medicine.
Contact Info
CGMH
Administration Center
No.199, Tunghwa Rd.
Taipei, Taiwan, R.O.C
886-2-27135211
http://www.cgmh.org.tw/eng2002/index.asp
Dr Yu-Ray Chen, Professor of Surgery at Chang Gung Memorial Hospital discusses the current state of Taiwan’s healthcare system, highlighting the fact that its current condition is unsustainable in the…
Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads…
Ting-Kuo Lee, Academician of Academia Sinica and chairman of the Taiwan Nanotechnology Industry Development Association, explains the history and mission of the association to promote Taiwan’s nano sector and gives…
HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then…
Katie Lai, associate director of Medpace Taiwan, introduces the company’s history in Taiwan and highlights the CRO’s unique service offering as a partner of choice to the biotech sector. Lai…
Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the…
Albert Lu (founder) and Helen Chiu (co-founder) of Tripod Nano Technology (TPNT), introduce the concept of the original innovative manufacturer (OIM) of metal nanoparticle colloidal solutions and highlight the company’s…
Dr Wen-je Ko, mayor of Taipei City, discusses his plans for creating a key biocluster in the city and goes on to share his views on the government’s role to…
Dr Chien-Huang Lin, tenth president of Taipei Medical University, shares his personal mission upon taking the role, elaborates on the research strengths of TMU, and goes on to discuss the…
Dr Fu-Tong Liu, vice president of Academia Sinica, introduces the institution and its research mission of promoting basic research and enhancing translation. Dr Liu goes on to describe Academia Sinica’s…
Betty Li, managing director of PPC, a well-positioned leader in the APAC CRO landscape, speaks about the strategic significance of the group’s Taiwan affiliate and goes on to share her…
Lily Wu, CEO of PapiVax, discusses the biotechs initiative pipeline for the treatment of HPV related diseases and cancers and goes on to elaborate the company’s development and future partnership…
Luke Chen, co-founder and CEO of PuriBlood, speaks about the innovative spin-off technology developed at the R&D Center for Membrane Technology at Chung Yuan Christian University. The company’s leukocyte reduction…
See our Cookie Privacy Policy Here
